undamentalytics Newsletter
Sign in

Progyny, Inc. revenue

Progyny, Inc.'s revenue was $1.29bn in fiscal 2025, up 10.4% on the year before. Since fiscal 2017 ($48.6m) it has grown at a compound 50.6% a year. Over the last twelve months it was $1.31bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue491052303455017871,0891,1671,2891,311
Growth on the year before—+116.9%+117.9%+50.1%+45.2%+57.2%+38.3%+7.2%+10.4%—
Gross profit7194670112167239253304322

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Fertility Benefit Services $831M 64.5% ▲ 13.9%
Pharmacy Benefit Services $458M 35.5% ▲ 4.6%

From Progyny, Inc.'s 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Progyny, Inc. $1.31bn 5.5% 11.0%
Healthequity, Inc. $1.36bn 7.3% 13.2%
Guardant Health, Inc. $1.18bn 42.7% 32.4%
Addus Homecare Corp $1.48bn 15.9% 13.9%
P3 Health Partners Inc. $1.50bn 2.8% 9.7%
Pennant Group, Inc. $1.10bn 37.9% 30.0%

Compare with peers

Head to head: HQY vs PGNYGH vs PGNYADUS vs PGNYPGNY vs PIII

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Progyny, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Progyny, Inc.